Pemphigus Vulgaris
What is Pemphigus Vulgaris?
Pemphigus vulgaris is a rare autoimmune disease that causes painful blisters on the skin and mucous membranes. Your immune system mistakenly attacks proteins that hold skin cells together. This creates blisters that break easily and leave raw, painful sores.
The condition most often starts in the mouth before spreading to the skin. It can affect people of any age but typically appears between ages 40 and 60. Without treatment, pemphigus vulgaris can become life-threatening. With proper care, most people can manage symptoms and live well.
This is not a contagious condition. You cannot spread it to others through contact. It happens when your body produces autoantibodies, which are proteins that attack your own healthy tissue instead of protecting you from illness.
Symptoms
- Painful blisters in the mouth, throat, or on the gums
- Blisters on the skin that break easily and ooze fluid
- Raw, painful sores where blisters have broken
- Difficulty eating or swallowing when mouth is affected
- Blisters on the scalp, chest, back, or other areas
- Skin that peels away with gentle pressure
- Crusting and oozing from affected areas
- Pain and tenderness in blistered areas
Most people notice mouth sores first, sometimes months before skin blisters appear. The blisters are fragile and rupture quickly, leaving painful wounds that heal slowly.
Concerned about Pemphigus Vulgaris? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Pemphigus vulgaris occurs when your immune system creates autoantibodies against desmoglein proteins. These proteins act like glue to hold skin cells together. When antibodies attack them, cells separate and blisters form. Doctors do not fully understand why the immune system makes this mistake.
Certain factors may increase your risk. Genetic background plays a role, with higher rates in people of Mediterranean, Middle Eastern, or Jewish descent. Some medications can trigger the condition, including blood pressure drugs called ACE inhibitors and a medication called penicillamine. Stress and injury to the skin may also trigger flares in people already prone to the disease.
How it's diagnosed
Doctors diagnose pemphigus vulgaris using a skin biopsy and specialized blood tests. A dermatologist will take a small sample of affected skin and examine it under a microscope. Direct immunofluorescence testing on the skin sample shows antibody deposits between skin cells.
Blood tests using indirect immunofluorescence can detect the specific autoantibodies in your bloodstream. These tests help confirm the diagnosis and monitor disease activity. This is specialized testing that requires coordination with a dermatologist or autoimmune specialist. Talk to your doctor about appropriate testing and next steps if you have symptoms.
Treatment options
- Corticosteroid medications to reduce immune system activity and inflammation
- Immunosuppressant drugs to prevent your body from making harmful antibodies
- Biologic medications that target specific parts of the immune response
- Rituximab, a medication that helps many people achieve remission
- Gentle wound care to prevent infection in open sores
- Soft, bland diet when mouth sores make eating difficult
- Avoiding triggers like certain medications or skin trauma
- Regular monitoring by a dermatologist to adjust treatment
- Antibiotics if bacterial infections develop in wounds
Frequently asked questions
Most people first notice painful blisters or sores inside the mouth. These may appear on the gums, tongue, throat, or inside the cheeks. Skin blisters often develop weeks or months later. The mouth sores can make eating and drinking uncomfortable.
No, pemphigus vulgaris is not contagious at all. You cannot catch it from someone else or spread it through contact. It is an autoimmune condition where your own immune system attacks your skin. It happens due to internal immune system problems, not external infection.
Diagnosis requires both a skin biopsy and blood tests. A dermatologist takes a small skin sample to look for antibody deposits using direct immunofluorescence. Blood tests using indirect immunofluorescence detect autoantibodies in your bloodstream. These tests together confirm the diagnosis.
There is no cure, but many people achieve long-term remission with treatment. Newer biologic medications like rituximab help many patients get their disease under control. Some people can eventually reduce or stop medications while staying in remission. Regular monitoring with your dermatologist is essential.
Treatment usually starts with corticosteroids to reduce inflammation quickly. Doctors add immunosuppressant drugs to control the immune response long-term. Rituximab, a biologic medication, has become a leading treatment for many patients. Your doctor will create a treatment plan based on how severe your disease is.
Response to treatment varies by person. Some people see improvement within weeks of starting medication. Others may take several months to get symptoms under control. Blisters and sores heal slowly, often taking weeks even with treatment. Patience and consistent treatment are important for the best outcomes.
Diet does not cure the condition, but eating soft, bland foods helps when you have mouth sores. Avoid spicy, acidic, or rough foods that can irritate open sores. Good nutrition supports healing and helps your body handle medication side effects. Stay hydrated, especially if mouth pain makes drinking difficult.
Untreated pemphigus vulgaris can become very serious or even life-threatening. Open sores can lead to severe infections and fluid loss. Before modern treatments, the condition had a high death rate. Today, with proper treatment, most people can manage the disease and live normal lives.
Yes, pemphigus vulgaris is the most common type. Pemphigus foliaceus causes more superficial blisters and usually spares the mouth. Paraneoplastic pemphigus is rare and linked to certain cancers. Other rare forms exist, but pemphigus vulgaris accounts for most cases.
Your doctor will monitor antibody levels regularly to track disease activity. Blood tests help determine if treatment is working and guide medication adjustments. Testing frequency depends on your disease severity and treatment response. Most people need monitoring every few months, especially when starting new treatments.